...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking...

7

Transcript of ...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking...

Page 1: ...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 2: ...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 3: ...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 4: ...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 5: ...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 6: ...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 7: ...Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on